We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

19 May 2026 - 22 May 2026
17 Jun 2026 - 19 Jun 2026

Improved Control for Anti-Coagulation Therapy

By HospiMedica staff writers
Posted on 14 Apr 2008
A new communication device helps clinicians obtain an overview of a patient's coagulation monitoring test results, making confident decision-making easier and leading to more successful therapy.

The CoaguChek XS Connect device is a small, compact, and easy to use device used to download international normalized ratio (INR) results from a CoaguChek XS system to a computer for efficient interpretation and subsequent action. More...
The device provides customizable reports and trend graphs, which can be reviewed on the computer screen, stored, and printed out. Only minimum computer literacy is required, and no software needs to be installed; the device is simply plugged into a universal serial bus (USB) port, and is recognized by the computer. The USB port also provides the power for the battery-free device. Results from the memory of the CoaguChek XS instrument can be viewed with a spreadsheet program such as Microsoft Excel, stored, or sent by e-mail. Data transfer to other software applications allows healthcare professionals to collect and further process patient data in their own office's environment. The CoaguChek XS system and the Connect device are products of Roche (Basel, Switzerland).

"The new CoaguChek XS Connect device has been designed to make these tasks easy, fast and convenient,” said Patrick Wieghardt, of Roche Professional Diagnostics. "Only three steps are required to download test results from a CoaguChek XS meter to a computer. This means, reduced risk of incorrect result reporting, and an easy-to-review overview for patients and healthcare professionals within seconds.”

Oral anti-coagulation therapy is an important treatment for patients with specific medical conditions such as mechanical heart valves, atrial fibrillation, or thromboembolic venous diseases. Frequent monitoring to support drug-dosing adjustments and to stay within the therapeutic range has proved to be an essential element in the success of every therapy.


Related Links:
Roche

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
New
Medical Adhesive
MED 5570U
New
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.